Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Depreciation & Amortization (CF) (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Depreciation & Amortization (CF) for 16 consecutive years, with $2.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 7.82% to $2.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $10.4 million, a 8.43% increase, with the full-year FY2025 number at $10.4 million, up 8.43% from a year prior.
  • Depreciation & Amortization (CF) was $2.6 million for Q4 2025 at Lemaitre Vascular, roughly flat from $2.6 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $2.9 million in Q3 2021 to a low of $2.3 million in Q4 2022.
  • A 5-year average of $2.5 million and a median of $2.4 million in 2023 define the central range for Depreciation & Amortization (CF).
  • Peak YoY movement for Depreciation & Amortization (CF): soared 70.61% in 2021, then fell 20.67% in 2022.
  • Lemaitre Vascular's Depreciation & Amortization (CF) stood at $2.9 million in 2021, then fell by 20.67% to $2.3 million in 2022, then grew by 6.77% to $2.4 million in 2023, then decreased by 1.11% to $2.4 million in 2024, then increased by 7.82% to $2.6 million in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Depreciation & Amortization (CF) are $2.6 million (Q4 2025), $2.6 million (Q3 2025), and $2.6 million (Q2 2025).